Overview

An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids

Status:
Completed

Trial end date:
2017-01-17

Target enrollment:

Participant gender:

Summary

This study intends to investigate patient satisfaction of treatment with Ointment (W/O emulsion) formulations of Potency Class II topical corticosteroids (TCs) for atopic dermatitis (AD) patients in Japan. Objectives include measuring patient satisfaction, treatment adherence, itchiness, and AD severity scores.

Details

Lead Sponsor:

Bayer
LEO Pharma

Collaborator:

Bayer

Treatments:

Diflucortolone
Diflucortolone valerate